Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo

James M Miller1 Department of Biology, New York University, New York, NY, USA

Sarah McNulty Bidula1 Department of Biology, New York University, New York, NY, USA;5 Present address Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Troels Mygind Jensen1 Department of Biology, New York University, New York, NY, USA;6 Present address: Univercity of Copenhagen, Copenhagen, Denmark

Carol Shoshkes Reiss1 Department of Biology, New York University, New York, NY, USA;2 Center for Neural Science, NYU;3 NYU Cancer Institute;4 Departments of Microbiology, NYU School of Medicine and Mt Sinai School of Medicine, New York, NY, USACorrespondence[email protected]

Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date